title: Ranitidine bismuth citrate plus azithromycin for Helicobacter pylori eradication.
authors.forename: L
authors.initials: L
authors.lastname: Bujanda
authors.forename: C
authors.initials: C
authors.lastname: Muñoz
authors.forename: A
authors.initials: A
authors.lastname: Sánchez
authors.forename: C
authors.initials: C
authors.lastname: Iriondo
authors.forename: A
authors.initials: A
authors.lastname: Cosme
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D016481:Helicobacter Infections / Q000175:diagnosis / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000382:microbiology; D011446:Prospective Studies; D011899:Ranitidine / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D017963:Azithromycin; D011899:Ranitidine